Talking to ET Now, Daljeet Singh Kohli, Head of Research, IndiaNivesh, says betting on two frontliners like Reliance and L&T which are subdued right now. What is your view on the pharmaceutical space? Would you have anything on your buy list? Read more here: Remain stock specific, bullish on 2 largecap stocks: Daljeet Singh Kohli, IndiaNivesh
Read More Here: Remain stock specific, bullish on 2 largecap stocks: Daljeet Singh Kohli, IndiaNivesh
No comments:
Post a Comment